Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Stichting Katholieke Universiteit maintains a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action, which represents the entirety of its active prosecution workload. This single action is assigned to the busiest examiner, TRAN, CHRISTINA L, who is managing 1 pending office action.
The prosecution is highly concentrated, involving only 1 distinct examiner and 1 distinct art unit. For a patent practitioner, this indicates that the portfolio's current USPTO interactions are limited to a very specific technical niche. The use of 1 distinct art unit suggests that the legal and technical arguments are focused on a single set of examination standards. Because all active work is funneled through TRAN, CHRISTINA L, the prosecution strategy does not need to account for varying examiner behaviors across different departments.
The presence of 1 pending office action means that the portfolio's immediate progress is entirely dependent on the resolution of this one matter. This singular focus allows for a direct relationship with the examiner but also centralizes the risk of delays. Practitioners can focus their resources on the specific history of TRAN, CHRISTINA L to optimize the response to the 1 pending office action. This lack of diversity in examiners and art units simplifies administrative management but requires a high degree of precision in the single active matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, CHRISTINA L | 1 | 51.6% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17298957 | Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4 | TRAN, CHRISTINA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17298957 | Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4 | TRAN, CHRISTINA L | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17298957 | Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4 | TRAN, CHRISTINA L | 1637 | §103§112 | Final Rejection | — | Pending | Jun 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialStichting Katholieke Universiteit has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christina L Tran has the most, with 1 of Stichting Katholieke Universiteit's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
